DOC Q1 2026 Earnings Massive EPS Beat of 515 Surprises Analysts Anika Therapeutics Q1 2026 Earnings Massive EPS Beat Defies Expectations SIRI Q1 2026 Earnings EPS Surpasses Estimates Yet Stock Declines COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains PRIM Q1 2026 Earnings EPS Misses Estimate by 315 Stock Still Climbs 69 RMR Q1 2026 Earnings EPS Misses Estimates but Stock Steadies